Literature DB >> 2279491

Estimates of the effective dose equivalent, HE, in positron emission tomography studies.

W Huda1, G A Sandison.   

Abstract

The effective dose equivalent, HE, can be used as a standard radiation dose parameter in all imaging modalities that use ionizing radiation, including positron emission tomography (PET). A simplified method for evaluating approximate HE values for the positron emitters carbon 11, nitrogen 13, oxygen 15 and fluorine 18 is presented. HE values for a range of PET studies have been computed based on biodistribution data available in the scientific literature. Low-dose PET studies include a bolus administration of 1030 MBq CO15O (HE = 1 mSv) and 74 MBq [18F]-L dopa (HE = 1.3 mSv). High-dose PET studies include a 1-h (steady-state) inhalation of a total of 9250 MBq C15OO (HE = 9.4 mSv). The mean HE value of 13 diverse PET studies was computed to be 4.5 mSv.

Entities:  

Mesh:

Year:  1990        PMID: 2279491     DOI: 10.1007/bf00811437

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  17 in total

1.  Some indicative parameters on diagnostic radiology in Spain: first dose estimations.

Authors:  E Vañó; L González; A Calzado; P Morán; V Delgado
Journal:  Br J Radiol       Date:  1989-01       Impact factor: 3.039

2.  Nuclear medicine staff and patient doses in Manitoba (1981-1985).

Authors:  W Huda; K Gordon
Journal:  Health Phys       Date:  1989-03       Impact factor: 1.316

3.  Radiation dose to patients from radiopharmaceuticals. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1987

4.  Radiation absorbed dose to bladder walls from positron emitters in the bladder content.

Authors:  G F Powell; C T Chen
Journal:  Med Phys       Date:  1987 Nov-Dec       Impact factor: 4.071

5.  Effective dose equivalent from radiopharmaceuticals.

Authors:  L Johansson; S Mattsson; B Nosslin
Journal:  Eur J Nucl Med       Date:  1984

6.  Absorbed dose estimates for positron emission tomography (PET): C15O, 11CO, and CO15O.

Authors:  K J Kearfott
Journal:  J Nucl Med       Date:  1982-11       Impact factor: 10.057

7.  Doses to patients from diagnostic radiology in France.

Authors:  C Maccia; M Benedittini; C Lefaure; F Fagnani
Journal:  Health Phys       Date:  1988-04       Impact factor: 1.316

8.  Patient doses from computed tomography in Manitoba from 1977 to 1987.

Authors:  W Huda; G A Sandison; T Y Lee
Journal:  Br J Radiol       Date:  1989-02       Impact factor: 3.039

9.  The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man.

Authors:  S C Jones; A Alavi; D Christman; I Montanez; A P Wolf; M Reivich
Journal:  J Nucl Med       Date:  1982-07       Impact factor: 10.057

10.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

View more
  4 in total

Review 1.  CT perfusion cerebral blood flow imaging in neurological critical care.

Authors:  Mark R Harrigan; Jody Leonardo; Kevin J Gibbons; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps.

Authors:  A Cenic; D G Nabavi; R A Craen; A W Gelb; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

3.  Pharmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans.

Authors:  H Herzog; R J Seitz; L Tellmann; G Schlaug; A Kleinschmidt; B Nebeling; G Stöcklin; H W Müller-Gärtner
Journal:  Eur J Nucl Med       Date:  1994-02

4.  PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs).

Authors:  G J Meyer; S L Waters; H H Coenen; A Luxen; B Maziere; B Langström
Journal:  Eur J Nucl Med       Date:  1995-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.